{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:33:28Z","timestamp":1790289208112,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T00:00:00Z","timestamp":1308960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s15010-011-0132-6","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T14:48:33Z","timestamp":1309013313000},"page":"333-340","source":"Crossref","is-referenced-by-count":137,"title":["Extended-spectrum \u03b2-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy"],"prefix":"10.1007","volume":"39","author":[{"given":"S.","family":"Meier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zbinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ruef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,25]]},"reference":[{"key":"132_CR1","first-page":"w13059","volume":"140","author":"J Nicoletti","year":"2010","unstructured":"Nicoletti J, Kuster SP, Sulser T, et al. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland. Swiss Med Wkly. 2010;140:w13059.","journal-title":"Swiss Med Wkly"},{"key":"132_CR2","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jac\/dki344","volume":"56","author":"H Arslan","year":"2005","unstructured":"Arslan H, Azap OK, Erg\u00f6n\u00fcl O, et al. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother. 2005;56:914\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"132_CR3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/QCO.0b013e3283398dc1","volume":"23","author":"J Oteo","year":"2010","unstructured":"Oteo J, P\u00e9rez-V\u00e1zquez M, Campos J. Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis. 2010;23:320\u20136.","journal-title":"Curr Opin Infect Dis"},{"key":"132_CR4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JD Pitout","year":"2008","unstructured":"Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159\u201366.","journal-title":"Lancet Infect Dis"},{"key":"132_CR5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1442-2042.2010.02500.x","volume":"17","author":"S Yamamoto","year":"2010","unstructured":"Yamamoto S, Higuchi Y, Nojima M. Current therapy of acute uncomplicated cystitis. Int J Urol. 2010;17:450\u20136.","journal-title":"Int J Urol"},{"key":"132_CR6","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/AAC.01760-09","volume":"54","author":"S Auer","year":"2010","unstructured":"Auer S, Wojna A, Hell M. Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. Antimicrob Agents Chemother. 2010;54:4006\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"132_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-0691.2007.01857.x","volume":"14","author":"DM Livermore","year":"2008","unstructured":"Livermore DM. Defining an extended-spectrum beta-lactamase. Clin Microbiol Infect. 2008;14:3\u201310.","journal-title":"Clin Microbiol Infect"},{"key":"132_CR8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JCM.42.3.1089-1094.2004","volume":"42","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2004","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol. 2004;42:1089\u201394.","journal-title":"J Clin Microbiol"},{"key":"132_CR9","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","volume":"168","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2008","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Alcal\u00e1 JC, Cisneros JM, et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med. 2008;168:1897\u2013902.","journal-title":"Arch Intern Med"},{"key":"132_CR10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jinf.2008.09.034","volume":"57","author":"KB Laupland","year":"2008","unstructured":"Laupland KB, Church DL, Vidakovich J, et al. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect. 2008;57:441\u20138.","journal-title":"J Infect"},{"key":"132_CR11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jac\/dkl035","volume":"57","author":"E Calbo","year":"2006","unstructured":"Calbo E, Roman\u00ed V, Xercavins M, et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother. 2006;57:780\u20133.","journal-title":"J Antimicrob Chemother"},{"key":"132_CR12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10096-003-1084-2","volume":"23","author":"R Colodner","year":"2004","unstructured":"Colodner R, Rock W, Chazan B, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis. 2004;23:163\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"132_CR13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1469-0691.2009.02941.x","volume":"16","author":"OK Azap","year":"2010","unstructured":"Azap OK, Arslan H, Serefhano\u011flu K, et al. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect. 2010;16:147\u201351.","journal-title":"Clin Microbiol Infect"},{"key":"132_CR14","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/604713","volume":"49","author":"R Ben-Ami","year":"2009","unstructured":"Ben-Ami R, Rodr\u00edguez-Ba\u00f1o J, Arslan H, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis. 2009;49:682\u201390.","journal-title":"Clin Infect Dis"},{"key":"132_CR15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1179\/joc.2008.20.5.581","volume":"20","author":"E Yilmaz","year":"2008","unstructured":"Yilmaz E, Akalin H, Ozbey S, et al. Risk factors in community-acquired\/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. J Chemother. 2008;20:581\u20135.","journal-title":"J Chemother"},{"key":"132_CR16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s15010-009-9207-z","volume":"38","author":"SP Kuster","year":"2010","unstructured":"Kuster SP, Hasse B, Huebner V, et al. Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection. 2010;38:33\u201340.","journal-title":"Infection"},{"key":"132_CR17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1086\/597505","volume":"30","author":"R Friedmann","year":"2009","unstructured":"Friedmann R, Raveh D, Zartzer E, et al. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol. 2009;30:534\u201342.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"132_CR18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"132_CR19","unstructured":"Clinical and Laboratory Standards Institute (CLSI) 2009. Performance standards for antimicrobial susceptibility testing, 17th informational supplement. CLSI, Wayne, PA; 2008."},{"key":"132_CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1469-0691.2005.01358.x","volume":"12","author":"C Pe\u00f1a","year":"2006","unstructured":"Pe\u00f1a C, Gudiol C, Tubau F, et al. Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect. 2006;12:279\u201384.","journal-title":"Clin Microbiol Infect"},{"key":"132_CR21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.urology.2006.08.1075","volume":"68","author":"J Ena","year":"2006","unstructured":"Ena J, Arjona F, Mart\u00ednez-Peinado C, et al. Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology. 2006;68:1169\u201374.","journal-title":"Urology"},{"key":"132_CR22","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.01614-06","volume":"51","author":"MF Lartigue","year":"2007","unstructured":"Lartigue MF, Zinsius C, Wenger A, et al. Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother. 2007;51:2855\u201360.","journal-title":"Antimicrob Agents Chemother"},{"key":"132_CR23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","volume":"10","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Kastoris AC, Kapaskelis AM, et al. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis. 2010;10:43\u201350.","journal-title":"Lancet Infect Dis"},{"key":"132_CR24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s10096-003-0893-7","volume":"22","author":"TY Ti","year":"2003","unstructured":"Ti TY, Kumarasinghe G, Taylor MB, et al. What is true community-acquired urinary tract infection? Comparison of pathogens identified in urine from routine outpatient specimens and from community clinics in a prospective study. Eur J Clin Microbiol Infect Dis. 2003;22:242\u20135.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"132_CR25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","volume":"10","author":"KK Kumarasamy","year":"2010","unstructured":"Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10:597\u2013602.","journal-title":"Lancet Infect Dis"},{"key":"132_CR26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/cid\/cir102","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, et al. Executive summary: International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:561\u20134.","journal-title":"Clin Infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-011-0132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-011-0132-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-011-0132-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T15:17:36Z","timestamp":1592666256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-011-0132-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,25]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1007\/s15010-011-0132-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717968450.793468131","asserted-by":"object"}]},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,25]]}}}